Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Roy

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Pathology|August 12, 2016
The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemiaSara Basbous, Anaïs Levescot, Nathalie Piccirilli, et al.
Leukemia & Lymphoma|October 9, 2010
Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemiaJean-Claude Chomel, Nathalie Sorel, Marie-Laure Bonnet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2012
p210bcr-abl induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1Tristan Rochelle, Thomas Daubon, Marleen Van Troys, et al.
Kidney International|January 14, 2004
High dose chemotherapy in light chain or light and heavy chain deposition diseaseBruno Royer, Bertrand Arnulf, Frank Martinez, et al.
The Journal of Molecular Diagnostics : JMD|May 29, 2010
Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemiaNathalie Sorel, Caroline Mayeur-Rousse, Séverine Deverrière, et al.
Blood|October 24, 2002
Megakaryocyte polyploidization is associated with a functional gene amplificationHana Raslova, Lydia Roy, Claire Vourc'h, et al.
Leukemia Research|October 3, 2008
Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML)Jean-Claude Chomel, Nathalie Sorel, Marie-Laure Bonnet, et al.
Blood|April 22, 2006
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trialsLydia Roy, Joëlle Guilhot, Tillmann Krahnke, et al.
British Journal of Haematology|March 14, 2019
Sustained treatment-free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T-cellsEmilie Cayssials, Florence Jacomet, Nathalie Piccirilli, et al.
Cancer Research|February 13, 2013
Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cellsLuana Casetti, Séverine Martin-Lannerée, Imen Najjar, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Pathology|August 12, 2016
The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemiaSara Basbous, Anaïs Levescot, Nathalie Piccirilli, et al.
Leukemia & Lymphoma|October 9, 2010
Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemiaJean-Claude Chomel, Nathalie Sorel, Marie-Laure Bonnet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2012
p210bcr-abl induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1Tristan Rochelle, Thomas Daubon, Marleen Van Troys, et al.
Kidney International|January 14, 2004
High dose chemotherapy in light chain or light and heavy chain deposition diseaseBruno Royer, Bertrand Arnulf, Frank Martinez, et al.
The Journal of Molecular Diagnostics : JMD|May 29, 2010
Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemiaNathalie Sorel, Caroline Mayeur-Rousse, Séverine Deverrière, et al.
Blood|October 24, 2002
Megakaryocyte polyploidization is associated with a functional gene amplificationHana Raslova, Lydia Roy, Claire Vourc'h, et al.
Leukemia Research|October 3, 2008
Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML)Jean-Claude Chomel, Nathalie Sorel, Marie-Laure Bonnet, et al.
Blood|April 22, 2006
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trialsLydia Roy, Joëlle Guilhot, Tillmann Krahnke, et al.
British Journal of Haematology|March 14, 2019
Sustained treatment-free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T-cellsEmilie Cayssials, Florence Jacomet, Nathalie Piccirilli, et al.
Cancer Research|February 13, 2013
Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cellsLuana Casetti, Séverine Martin-Lannerée, Imen Najjar, et al.
Pageof 7